OraSure Technologies | OSUR - Assets


OraSure Technologies reported $379.17M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agilent USD 12.81B 86M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Bio Techne USD 2.55B 27.9M Mar/2026
Bio-Rad Laboratories USD 9.79B 786.5M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Cerus USD 221.86M 6.67M Dec/2025
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Dexcom USD 6.63B 293.4M Mar/2026
Illumina USD 6.56B 85M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
Intuitive Surgical USD 20.11B 347.7M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Mettler Toledo International USD 3.67B 43.73M Mar/2026
Myriad Genetics USD 673.7M 32.9M Mar/2026
OraSure Technologies USD 379.17M 24M Mar/2026
Quidel USD 5.63B 140.6M Mar/2026
Repligen USD 2.93B 18.93M Mar/2026
Revvity USD 12B 171.82M Mar/2026
STAAR Surgical USD 451.12M 560K Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Trinity Biotech USD 103.71M 4.08M Sep/2025
Waters USD 24.53B 19.45B Mar/2026